A new study by researchers at Fox Chase Cancer Center focusing on pancreatic cancer has shown that a new scoring system can ...
A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...
LUND, Sweden, April 17, 2026 (GLOBE NEWSWIRE) -- Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announces that it ...
The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka factors, proteins ...
Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...
Therapeutic fasting offers a metabolic approach to chronic pain by shifting to fat metabolism, reducing systemic inflammation ...
In this excerpt from “We Are As Gods: A Survival God for the Age of Abundance,” authors Peter H. Diamandis and Steven Kotler ...
From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results